Robert H. Lurie Comprehensive Cancer Center of Northwestern University Northwestern Medicine | Strategic Alliance Partners

At Northwestern Medicine, we put our patients first in an effort to deliver the best cancer care. Our teams of experts are here to help support patients and their caregivers during all stages of their cancer journey: diagnosis, treatment, and recovery.

Northwestern Medicine’s cancer centers provide access to state-of-the art therapies and comprehensive cancer care offering leading-edge medical, surgical and radiation oncology treatment options, as well as access to specialized research, clinical trials and diagnostic services.

Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital is proud to be ranked as one of the top 8 cancer programs in the country by U.S. News & World Report.

Latest from Robert H. Lurie Comprehensive Cancer Center of Northwestern University Northwestern Medicine

Powerful Chemotherapy Drug Reaches Brain Tumors Using Novel Ultrasound Technology

May 25, 2023

Article

Northwestern Medicine scientists report results of the first in-human clinical trial in which they used a novel, skull-implantable ultrasound device to open the blood-brain barrier and repeatedly permeate large, critical regions of the human brain to deliver chemotherapy that was injected intravenously.

Closing Thoughts on Intralesional Therapy for Melanoma and CSCC

May 24, 2023

Video

A panel of skin cancer experts offer closing thoughts on intralesional therapy for treating melanoma and CSCC.

Northwestern Medicine Successfully Performs Double-lung Transplant on a Second Patient With Stage 4 Lung Cancer and Launches First-of-its-kind Clinical Program

May 23, 2023

Article

For the second time at Northwestern Medicine, surgeons have successfully performed a double-lung transplant on a patient with stage 4 lung cancer who was being considered for hospice.

Tumor-Directed Oncolytic Therapies for Melanoma and CSCC

May 17, 2023

Video

An expert panel discusses the use of tumor-directed oncolytic therapies for melanoma and cutaneous squamous cell carcinoma.

Treating Patients with High-Risk Melanoma

May 17, 2023

Video

A comprehensive overview of treatment approaches for patients with high-risk melanoma.

Meaningful End Points for Patients with Metastatic Melanoma

May 10, 2023

Video

Experts on skin cancer discuss valuable end points for determining successful treatments for patients with metastatic melanoma.

Deciding Between Melanoma Therapy Options

May 10, 2023

Video

A panel of skin cancer experts share their thoughts on treatment selection for patients with melanoma.

BRAF/MEK Dual Inhibitors for Melanoma

May 03, 2023

Video

An expert panel analyzes BRAF/MEK dual inhibitor therapy for the treatment of melanoma.

Factors that Impact Treatment Selection for Melanoma

May 03, 2023

Video

Anna C. Pavlick, DO, discusses factors that impact treatment selection for patients with melanoma.

Future Treatment Landscape for Squamous Cell Carcinoma

April 26, 2023

Video

Expert oncologists look to the future of treatment for cutaneous squamous cell carcinoma.

Treatment Duration Considerations for CSCC

April 26, 2023

Video

Skin cancer expert Anna C. Pavlick, DO, discusses treatment duration approaches for cutaneous squamous cell carcinoma.

CSCC Treatment Options: Cemiplimab and Pembrolizumab

April 19, 2023

Video

Nikhil Khushalani, MD, gives a comprehensive overview of cemiplimab and pembrolizumab for treating CSCC.

Choosing Systemic Therapies for Patients with Unresectable or Metastatic CSCC

April 19, 2023

Video

Anna C. Pavlick, DO, overviews systemic therapy options for patients with unresectable or metastatic CSCC.

Multidisciplinary Management of CSCC

April 12, 2023

Video

Nikhil Khushalani, MD, discusses the multidisciplinary team approach to treating patients with cutaneous squamous cell carcinoma.

Unmet Needs and Prognosis for CSCC and Melanoma

April 12, 2023

Video

Skin cancer experts discuss prognosis and unmet needs in the cutaneous squamous cell carcinoma and melanoma treatment spaces.

Dr Barber on the Significance of the KEYNOTE-775 Trial for the Second-line Treatment of Endometrial Cancer

April 04, 2023

Video

Emma L. Barber, MD, discusses how key data from the phase 3 KEYNOTE-775 study improved the identification of patient populations within endometrial cancer that benefit from second-line immunotherapy.

Overview of Cutaneous Squamous Cell Carcinoma and Melanoma

March 31, 2023

Video

A panel of skin cancer experts give an overview of cutaneous squamous cell carcinoma and melanoma.

Dr. Roque on the Importance of Biomarker Testing in Advanced Endometrial Cancer

March 23, 2023

Video

Dario R. Roque, MD, discusses how biomarker testing can lead to more accurate and effective treatment selection in advanced endometrial cancer.

Dr. Hussain on Retrospective Analysis of the ARASENS trial in mHSPC

March 08, 2023

Video

Maha H. Hussain, MD, FASCO, FACP, discusses key efficacy and safety data from a secondary analysis of the phase 3 ARASENS trial in metastatic hormone-sensitive prostate cancer.

Dr. Barber on the Role of Molecular Profiling for Treatment Considerations in Endometrial Cancer

February 23, 2023

Video

Emma L. Barber, MD, discusses the role of molecular profiling for treatment considerations in patients with endometrial cancer.